Bart Meuris

Introduction The number of patients with severe aortic valve disease requiring either surgical bioprosthetic aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) is increasing worldwide with the increasing aging population. For many years, SAVR has been the method of choice and a routine procedure for symptomatic patients with severe aortic valve disease or selected asymptomatic patients (1).

After publication of the original article, the author noticed some errors to the article which are included in this erratum. The short title should read: Systematic Review: Pre-clinical In Vitro Models for Vascular Graft Coating and Infection. The titles for Tables 1, 2 and 3 and Figure 1 should read: Table 1. Vascular grafts and coating in pre-clinical in vitro models for vascular graft coating and infection Table 2.

Objective The aim of this study was to investigate the efficacy of vascular graft coatings used in the aortic position to prevent vascular graft infection (VGI). Methods A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines using a pre-registered protocol (CRD42020206436). Eligible studies used a vascular graft coating in the aortic position and reported on VGI.